Taiwan FDA registration 8006d4e2c28525368c3c3684a1c28f3a

"Porulti" Porto (including lidocaine)

TW: “保柔緹”保柔(含利多卡因)

Taiwan·Risk Class 3·ANTEIS SA;; Anteis S.A.·Registered Mar 30, 2018 – Mar 30, 2028Active

Registration details

Analysis ID: 8006d4e2c28525368c3c3684a1c28f3a
Customs Code: DHA05603097308

Company information

Manufacturer: ANTEIS SA;; Anteis S.A.
Manufacturer Country: Switzerland
Authorized Representative: MERZ ASIA PACIFIC PTE. LTD. TAIWAN BRANCH (SINGAPORE)

Product details

Intended Use: This product is an absorbable injectable implant used to increase the volume of skin tissue to: ‧Correct facial hollowness caused by injury and age. ‧Facial contouring such as cheeks, chin, etc. ‧Lip augmentation (red edge of lips, increase three-dimensional curvature). ‧Treatment of nasolabial folds in depth
Product Type (Level 1): I General, Plastic Surgery and Dermatology
Product Type (Level 2): I.0007 Hyaluronic acid implants
Import Information: Input;; The use of this device shall comply with the provisions of the Administrative Measures for the Implementation or Use of Medical Devices for Specific Medical Technology Inspection and Testing.

Dates and status

Registration Date: Mar 30, 2018
Expiry Date: Mar 30, 2028

About this record

Access comprehensive regulatory information for "Porulti" Porto (including lidocaine) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 8006d4e2c28525368c3c3684a1c28f3a and manufactured by ANTEIS SA;; Anteis S.A.. The authorized representative in Taiwan is MERZ ASIA PACIFIC PTE. LTD. TAIWAN BRANCH (SINGAPORE).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.